Status:
UNKNOWN
Comparison Between Testosterone and Estradiol Over the Homogenization of Follicular Cohort
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Conditions:
Fertility Disorders
Eligibility:
FEMALE
18-39 years
Phase:
PHASE3
Brief Summary
In vitro fertilization(IVF) with Gonadotropin-releasing hormone (GnRH) antagonist is one of the most used protocol for the treatment of infertile couples nowadays. Despite several advantages over GnRH...
Detailed Description
One of the key-words to a successful IVF it is the response to the ovarian controlled stimulation. Nowadays, one of the most common protocols includes exogenous gonadotropins and GnRH antagonist, foll...
Eligibility Criteria
Inclusion
- Regular cycles (between 25-34 days)
- In vitro fertilization indication for male cause, unexplained infertility or tubal factor
- Both ovaries
- Thyroid-stimulating hormone(TSH) \< 2,5 mU/L
- Anti-Müllerian hormone (AMH) between 1-5 ng/ml
- Body Mass Index (BMI) \< 30
Exclusion
- Ovarian surgery
- Endometriosis
- Endocrinology or metabolic disorder
- Polycystic ovary syndrome (PCOS)
- Poor Ovarian Response (according to Bologna criteria)
Key Trial Info
Start Date :
August 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2018
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT03238092
Start Date
August 1 2017
End Date
March 1 2018
Last Update
August 3 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.